Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

REPAGLINIDE 1 MG

REPAGLINIDE : 1 MG · DIN 02415976 · PRO DOC LIMITEE

Health Canada status: MARKETED

What is REPAGLINIDE?

REPAGLINIDE 1 MG contains REPAGLINIDE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02415976, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Dec-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is REPAGLINIDE used for?

Repaglinide is indicated as an adjunct to diet and exercise to lower blood glucose in patients with type 2 diabetes mellitus whose hyperglycemia cannot be controlled by diet and exercise alone. It can also be used in combination therapy with metformin or with rosiglitazone (for patients intolerant or contraindicated to metformin) when diet and exercise plus monotherapy do not provide adequate glycemic control.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02415976
Brand nameREPAGLINIDE
Generic / active ingredientREPAGLINIDE : 1 MG
ManufacturerPRO DOC LIMITEE
Strength1 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeA10BX02 REPAGLINIDE
AHFS class68:20.16
BiosimilarNo
Health Canada statusMARKETED
Status date16-Dec-2016
Original market date2013-11-28 00:00:00

How is it stored and handled?

null

How is it supplied?

null

What can be used instead?

Other Canadian products sharing ATC code A10BX02 REPAGLINIDE. 12 of 27 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AURO-REPAGLINIDE0.5 MGTABLETAURO PHARMA INCMARKETEDDIN 02424258
AURO-REPAGLINIDE1 MGTABLETAURO PHARMA INCMARKETEDDIN 02424266
AURO-REPAGLINIDE2 MGTABLETAURO PHARMA INCMARKETEDDIN 02424274
JAMP REPAGLINIDE0.5 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02354926
JAMP REPAGLINIDE1 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02354934
JAMP REPAGLINIDE2 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02354942
REPAGLINIDE0.5 MGTABLETPRO DOC LIMITEEMARKETEDDIN 02415968
REPAGLINIDE2 MGTABLETPRO DOC LIMITEEMARKETEDDIN 02415984
SANDOZ REPAGLINIDE0.5 MGTABLETSANDOZ CANADA INCORPORATEDMARKETEDDIN 02357453
SANDOZ REPAGLINIDE1 MGTABLETSANDOZ CANADA INCORPORATEDMARKETEDDIN 02357461

Who else supplies REPAGLINIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. REPAGLINIDE appears in 103 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for REPAGLINIDE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for REPAGLINIDE

Health Canada Drug Product Database (DPD), DIN 02415976. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.